These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pulmonary embolism thrombolysis: Do we need another agent? Goldhaber SZ Am Heart J; 1999 Jul; 138(1 Pt 1):1-2. PubMed ID: 10385751 [No Abstract] [Full Text] [Related]
5. Thrombolytic Therapy of Acute Massive Pulmonary Embolism Using Swan-Ganz Pulmonary Artery Catheter. Espina I; Varon J; Lin PH Ann Vasc Surg; 2017 Aug; 43():315.e9-315.e12. PubMed ID: 28479425 [TBL] [Abstract][Full Text] [Related]
6. [A case of successful application of tissue plasminogen activator actilyse in complex intensive therapy for massive pulmonary artery embolism]. Mierbekov EM; Artykbaev ZhT; Potseluev DD Anesteziol Reanimatol; 2004; (2):67-70. PubMed ID: 15206285 [No Abstract] [Full Text] [Related]
7. Massive pulmonary embolism: treatment with thrombus fragmentation and local fibrinolysis with recombinant human-tissue plasminogen activator. Stock KW; Jacob AL; Schnabel KJ; Bongartz G; Steinbrich W Cardiovasc Intervent Radiol; 1997; 20(5):364-8. PubMed ID: 9271647 [TBL] [Abstract][Full Text] [Related]
8. [Renal artery embolism treated by selective intra-arterial infusion of tissue plasminogen activator: report of 2 cases]. Inoue T; Iwamura H; Kanematsu A; Hiura M; Kakehi Y; Hashimura T Hinyokika Kiyo; 1997 Sep; 43(9):655-9. PubMed ID: 9365846 [TBL] [Abstract][Full Text] [Related]
9. Treatment of a massive pulmonary embolism using pulse-spray thrombolysis in a patient with central nervous system infection: a risk or the adequate choice? Radej J; Matejovic M; Krouzecky A; Kulda J; Novak M; Novak I Acta Anaesthesiol Scand; 2006 May; 50(5):645-6. PubMed ID: 16643253 [No Abstract] [Full Text] [Related]
11. Hybrid method in severe pulmonary embolism not suitable for systemic fibrinolysis. Hang Luk W; Chan HF; Pan NY; Tse KH; Cheng LF; Ma JKF Asian Cardiovasc Thorac Ann; 2017; 25(7-8):544-546. PubMed ID: 28949255 [TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator as an alternative to vena cava interruption in recurrent pulmonary thromboembolism. Hunker FD; Mason RE; Browne SD South Med J; 1990 Nov; 83(11):1305-6. PubMed ID: 2122525 [TBL] [Abstract][Full Text] [Related]
13. Thrombolytic treatment with recombinant tissue-type plasminogen activator in a patient with massive pulmonary embolism. Bounameaux H; Vermylen J; Collen D Ann Intern Med; 1985 Jul; 103(1):64-5. PubMed ID: 4039905 [No Abstract] [Full Text] [Related]
15. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Verstraete M; Miller GA; Bounameaux H; Charbonnier B; Colle JP; Lecorf G; Marbet GA; Mombaerts P; Olsson CG Circulation; 1988 Feb; 77(2):353-60. PubMed ID: 3123091 [TBL] [Abstract][Full Text] [Related]
16. Intraarterial subclavian artery thrombolysis in a neonate. Neff KW; Dinter D; Schaible T; Lehmann KJ; Düber C AJR Am J Roentgenol; 2001 Aug; 177(2):446-8. PubMed ID: 11461880 [No Abstract] [Full Text] [Related]
17. Efficacy evaluation of reteplase in a novel canine acute pulmonary thromboembolism model developed by minimally invasive surgery and digital subtraction angiography. Zhang Y; Liu H; Zhang Y; Wu Q; Zhang Y; Zhang J; Zhou X; Jiao H; Fan F; Xue Q; Wang X; Zhong Z Drug Des Devel Ther; 2018; 12():3717-3730. PubMed ID: 30464403 [TBL] [Abstract][Full Text] [Related]
18. [Successful thrombolytic therapy in massive pulmonary embolism and right atrial thrombus--presentation of 2 case reports]. Thoma S; Zahn R; Bachor A; Senges J Med Klin (Munich); 1996 Nov; 91(11):725-8. PubMed ID: 9036299 [No Abstract] [Full Text] [Related]